维普中文期刊产品整合服务
647篇 您的检索式:作者名="Gl P"
    题名 作者 年代 出处 被引量
1Prospective validation of %p2PSA and the Prostate Health Index, in prostate cancer detection in initial prostate biopsies of Asian men, with total PSA 4-10 ng ml-1显示文摘尽管有它为屏蔽的前列腺癌症的普遍使用,低特性使 PSA 成为非最优的 biomarker,特别在 4-10 ng ml 1 的诊断灰色的地区。假积极与伴随的病态导致不必要的活体检视。这在与在 4.0 和 10 ng ml 1 之间的全部的 PSA 介绍的亚洲人是 % p2PSA 和前列腺健康索引(PHI ) 的第一未来的确认研究。我们学习了在 50 和 75 岁之间的 157 个亚洲人,与每直肠的前列腺考试的正常,经历他们的第一前列腺活体检视,用一个标准化活体检视协议,为 4-10 ng ml 1 的 PSA 层次。(19.1%) 三十被发现在活体检视上有前列腺癌症。有或没有前列腺癌症的病人之间的统计上重要的差别被作出对有利的裁决全部的 PSA, p2PSA, % p2PSA,和 PHI。在为全部的 PSA, % fPSA, % p2PSA,和 PHI 操作典型曲线的接收装置的曲线下面的区域分别地是 0.479, 0.420, 0.695,和 0.794。PHI 最好预言 prostatic 活体检视结果。在 90% 的敏感, PHI 的特性(95% CI ) 是 58.3% ,多于在 17.3% 点使全部的 PSA 的特性增加两倍,潜在地避免 77 (49%) 不必要的活体检视。类似于研究在主要白种人人口,我们有希望地证明了 % p2PSA 和 PHI 极大地超过总数并且释放总计 PSA 比率,在前列腺癌症的察觉起初活体检视。更高的 PHI 层次也对应于增加检测 GS 7 癌症的风险。我们验证了 PHI 的使用与在 4 和 10 ng ml 1 之间的浆液 PSA 在亚洲人关于前列腺活体检视帮助决策。Lincoln GL Tan Yung Khan Tan Bee Choo Tai Karen ML Tan Vineet Gauhar Ho Yee Tiong Robert CW Hawkins Thomas P Thamboo Felicia SK Hong Edmund Chiong 2017Asian Journal of Andrology2017,19,3:13
2Oligodendroglioma: CD44 as a possible prognostic opportunity显示文摘CD44, in its standard form as well in its isoforms, is a cell surface adhesion glycoprotein which occurs in a widevariety of non-neoplastic and neoplastic ceils. CD44 has been considered to be implicated in tumoral growth andin metastatic potential. We studied the immunohistochemical expression of CD44 standard in 30 oligodendrogliomas(19 primary lesions and 11 recurrences) in order to verify its possible prognostic role. Twelve primary oligoden-Buccoliero AM Caldarella A Arganini L Mennonna P Ammanati F Taddei A Taddei GL 2003中国神经肿瘤杂志2003,1,3:8
3卒中介入治疗培训指南:国际多学会共识文件显示文摘1背景 缺血性卒中是全球人口死亡和残疾的首要原因。很多急性大血管闭塞(emergent large vesselocclusion,ELVO)患者都会遗留长期残疾。事实上,这些颅内大动脉闭塞经常会导致大面积脑损伤,进而造成患者死亡或严重致残。Lavine SD Cockroft K Hoh B Bambakidis N Khalessi AA Woo H Riina H Siddiqui A Hirsch JA Chong W Rice H Wenderoth J Mitchell P Coulthard A Signh TJ Phatorous C Khangure M Klurfan P ter Brugge K Iancu D Gunnarsson T Pongpech S Rodesch G Soderman M Taylor A Krings T Orbach D Picard L Suh DC Zheng HQ Jansen O Muto M Szikora I Pierot L Brouwer P Gralla J Renowden S Andersson T Fiehler J Turjman F White P Januel AC Spelle L Kulcsar Z Chapot R Biondi A Dima S Taschner C Szajner M Krajina A Sakai N Matsumaru Y Yoshknura S Ezura M Fujinaka T Iihara K Ishii A Higashi T Hirohata M Hyodo A Ito Y Kawanishi M Kiyosue H Kobayashi E Kobayashi S Kuwayama N Matsumoto Y Miyachi S Murayama Y Nagata I Nakahara I Nemoto S Niimi Y Oishi H Satomi J Satow T Sugiu K Tanaka M Terada T Yamagami H Diaz O Lylyk P Jayaraman MV Patsalides A Gandhi CD Lee SK Abruzzo T Albani B Ansari SA Arthur AS Baxter BW Bulsara KR Chen M Almandoz JE Fraser JF Heck DV Hetts SW Hussain MS Klucznik RP Leslie-Mawzi TM Mack WJ McTaggart RA Meyers PM Mocco J Prestigiacomo CA Pride GL Rasmussen PA Starke RM Sunenshine PJ Tarr RW Frei DF Pabo M Nogueira RG Zaidat OO Jovin T Linfante I Yavagal D Liebeskind D Novakovic R Pongpech S 许岩 孙瑞 郭芮兵 2017国际脑血管病杂志2017,25,5:2
4颈动脉硬化进展与病程≥10年的高血压治疗之间的关系:多种族动脉粥样硬化研究显示文摘尚未有前瞻性多种族队列对抗高血压药物类别和动脉硬化进展的相关性进行研究。该研究所有受试者基线均患高血压,定义为血压≥140/90 mm Hg(1mm Hg=0.133kPa)或服用降压药物治疗。在5个时间点评估药物的服用情况和血压水平。通过超声在基线时和平均随访(9.4±0.5)年后测定右颈总动脉的杨氏弹性模量和扩张系数。Gepner AD Tedla Y Colangelo LA Tattersall MC Korcarz CE Kaufman JD Liu K Burke GL Shea S Greenland P Stein JH 刘莉 叶鹏 2016中华高血压杂志2016,24,11:2
5Inhibition of antoantibody binding to platelet glycoprotein Ⅱb/Ⅲa by anti-idiotypic antibodies in intravenous gammaglobulin显示文摘 Dale GL Tani P 1989Blood1989,74,:1
6Video-assisted thyroidectomy : indications and resuhs显示文摘Miccoli P Berti P Frustaci GL 2006Langenbecks Arch Surg2006,391,2:1
7Lessons learned from marketed and investigational prodrugs显示文摘Ettmayer P Amidon GL Clement B 2004J Med Chem2004,47,10:1
8Cost effectiveness of nurse led secondary prevention clinics for coronary heart disease in primary care :follow up of a randomised controlled trial显示文摘Raftery JP Yao GL Murchie P 2005BMJ2005,330,7493:1
9Video-assisted thyroidectomy: indications and results 显示文摘Miccoli P Berti P Frustaci GL 2006Langenbecks Arch Surg2006,391,2:1
10Lipid infusion accelerates removal of bupivacaine and recovery from bupivacain toxicity in the isolated rat heart显示文摘Weinberg GL Ripper R Murphy P 2006Reg Anesth pain Med2006,31,4:1
11general anaesthetics selectively modulate glutamatergic and dopaminergic signaling via site-specific phosphorylation in vivo显示文摘Snyder GL Galdi S Hendrick J P 2007Neuropharmacology2007,53,5:1
12Is baremetal stenting superior to balloon angioplasty for small vessel coronary artery disease? Evidence from a meta-analysis of randomizedtrials 显示文摘Agostoni P Biondi-Zoccai GG Gasparini GL 2005Eur Heart J2005,26,9:1
13A phase 1I study ofmoderate hypothemia in severe brain injury显示文摘Clifton GL Allen S Barrodale P et a1 1993J Neurotrauma1993,10,3:1
14Anti - Ta - H, a humanized antibody to the interleukin 2 receptor,prolongs primate cardiac allograft survival显示文摘Brown J P Parenteau GL Dirbas 1991Proc Natl Acad Sci USA1991,88,:1
15Activation of protein kinase C isoforms and its impact on diabetic complications 显示文摘C eraldes P King GL 2010Circ Res2010,106,8:1
16Aphase strdy of moderate hypothermia in severe brain injury显示文摘Clifton Gl Allen S Barrodale P 1993J Neurotrauna1993,10,3:1
17Lipid infusion ac- celerates removal of bupivaeaine and recovery from bupiva- caine toxicity in the isolated rat heart显示文摘Weinberg GL Ripper R Murphy P 2006Reg Anesth Pain Med2006,31,4:1
18ST segment elevation acute myo- cardial infarction reperfusion at any cost显示文摘Abbate A Agostoni P Biandi-Zoccai GL 2005Eur heart2005,26,18:1
19Identification of a RAPD marker linked to the pendula gene in Norway spruce (Picea abies (L.) Karst. f. pendula)显示文摘A. Lehner M. A. Campbell N. C. Wheeler T. P?ykk? J. Gl?ssl J. Kreike D. B. Neale 1995Theoretical and Applied Genetics (-)1995,,6:1
20A review of the use of magnetic resonance imaging in Parkinson's disease显示文摘Nadya P Cécile G Daniel GL 2014Ther Adv Neurol Disord2014,7,:1
返回顶部 每页显示:
共33页 首页 上一页 第1页 下一页 末页 /33 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费